Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > "Golden bullet" shows promise for killing common parasite

Abstract:
Researchers in Australia report development of a new type of gold nanoparticle that destroys the parasite responsible for toxoplasmosis, a potentially serious disease acquired by handling the feces of infected cats or eating undercooked meat. Their so-called "golden bullet" could provide a safer, more effective alternative for treating the disease than conventional drug therapy, they say. The study is scheduled for the Dec. issue of ACS' Nano Letters, a monthly journal.

"Golden bullet" shows promise for killing common parasite

Sydney, Australia | Posted on December 5th, 2007

Toxoplasma gondii, the parasite that causes the disease, infects more than 60 million people in the United States alone. Although most infected people have no symptoms, it can cause serious health problems in pregnant women and individuals such as AIDS patients or organ transplant recipients who have weakened immune systems.

In the new study, Michael Cortie and colleagues attached antibodies to the parasite onto gold nanorods that are activated by laser-light. A group of Toxoplasma-infected animal cells were isolated in cell culture dishes and subsequently exposed to these "golden bullets." The cells were then exposed to laser-light, which heated up the "bullets" and destroyed the parasites. The treatment killed about 83 percent of the parasites containing the gold particles, the researchers say. They hope to develop a similar technique for killing the parasite in patients.

####

For more information, please click here

Contacts:
Michael B. Cortie, Ph.D.
University of Technology Sydney
Sydney, Australia
Phone: 61 02 9514 2208

Copyright © American Chemical Society

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

DOWNLOAD PDF

Related News Press

Nanomedicine

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014

Discoveries

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

Announcements

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE